Dr. Jonette Elizabeth Keri, MD, PhD

Dr. Keri practices at UMiami Medicine - Dermatology in Miami, Florida.

Dr. Keri's NPI, 1053396150, was assigned on December 12, 2005. Dr. Keri graduated from Georgetown University School Of Medicine in 1996. Dr. Keri holds Florida license ME78553.

Dr. Keri's primary practice is UMiami Medicine - Dermatology, at 1444 NW 9th Ave, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 243-7688.

Dr. Keri's primary practice is UMiami Medicine - Dermatology in Miami, Florida. Dr. Keri is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Keri practices. Vendor and product names are available with a free account.

Dermatology is Dr. Keri's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Keri is board certified in dermatology by the American Board of Dermatology. Dr. Keri is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, itchy rashes, rash, scalp rash and shingles among the conditions Dr. Keri treats.

CMS data shows 317 Medicare services from Dr. Keri across 8 procedure codes in 2024, for 123 Medicare patients. Medicare paid $18,683 for them. Every service was in an office.

CMS counts 123 Medicare patients who saw Dr. Keri in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 11% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Keri's median patient age at 52, with 52% women.

In 2024, Dr. Keri wrote 219 Medicare Part D claims for 66 patients. 94% of them were for generic drugs. CMS names the drug for 92 of them, across 5 drugs with 11 or more claims each, at $1,437 in total drug cost. In 2023, CMS named 121 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Keri for performance year 2024, reported as part of a group. Dr. Keri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 145 procedures of removal of skin lesions by Dr. Keri, more than 77% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 41 papers to Dr. Keri, published from 2009 to 2024. 2017 was the busiest year, with 3. The most frequent topics are Acne Vulgaris, Skin and Administration, Cutaneous. Dr. Keri has published most often in J Am Acad Dermatol. Dr. Keri's most frequent co-authors are Marita Yaghi, MD, Shasa Hu, MD and Keyvan Nouri, MD.

CMS Open Payments shows 73 general payments to Dr. Keri from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 53% of the total. VYNE Pharmaceuticals Inc. paid the most, $10,280.

Dmand AI lists 2 awards for Dr. Keri, most recently CMS Stage 1 EHR in 2013.

Dr. Keri graduated from Georgetown University School Of Medicine in 1996. Dr. Keri is a member of AAD.

Dr. Keri is in network with 11 carriers, including Elevance, Aetna and United Healthcare. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.